Uncategorized

Whoopie pie war escalates

The whoopie pie war is on. Pennsylvania residents are planning to hold a rally Saturday to protect their heritage and claim the whoopie pie as their own. The event is being organized by Lancaster resident Nick Martin in response to recent events in Maine, where lawmakers are seeking to designate the whoopie pie as the […]

Read more

Aveo, Astellas in potential $1.3b cancer drug deal

Aveo Pharmaceuticals Inc. of Cambridge announced a partnership that could be worth more than $1.3 billion with Astellas Pharma on Aveo’s lead drug candidate, the cancer treatment tivozanib. Japanese drugmaker Astellas agreed to pay Aveo $125 million up front. Aveo could receive $575 million if tivozanib reaches clinical development and regulatory milestones, while sales milestone […]

Read more

EMD Serono marks opening of Billerica R&D facility

EMD Serono, the Massachusetts biopharmaceutical division Merck KGaA, held an official opening ceremony today for a new $65 million research-and-development facility in Billerica that will initially create about 100 new jobs. Merck, a chemical and pharmaceutical giant headquartered in Germany, will now have four research hubs deployed around the globe, and the Billerica site will […]

Read more

Momenta logs MS generic victory

Cambridge-based Momenta Pharmaceuticals has been granted a patent that will help the company advance its drug target for a generic form of Teva Pharmaceutical Industries’ multiple sclerosis treatment Copaxone, the Boston Business Journal reports. The approval capped a good day for Momenta and a not-so-good one for Teva, which reported that profits fell short of […]

Read more

H3 Biomedicine launches with $200M from Eisai

Eisai Inc. launched on Thursday a wholly owned research and development subsidiary in Cambridge called H3 Biomedicine Inc. that will focus on personalized cancer medicines based on cancer genetics and chemistry advances. Eisai, the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd., has pledged up to $200 million in research funding, plus more for clinical […]

Read more

Robot firm is moving to Hub’s Innovation District

Heartland Robotics Inc. said it is relocating its corporate headquarters and product development efforts from Cambridge to an area of Boston’s Fort Point Channel neighborhood that falls within what Mayor Thomas M. Menino has dubbed the “Innovation District.” The company, which is developing a new generation of intelligent robots to increase productivity in manufacturing environments, […]

Read more

Compare